These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 32422376)
1. Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report. Franzetti M; Pozzetti U; Carugati M; Pandolfo A; Molteni C; Faccioli P; Castaldo G; Longoni E; Ormas V; Iemoli E; Piconi S Int J Infect Dis; 2020 Aug; 97():215-218. PubMed ID: 32422376 [TBL] [Abstract][Full Text] [Related]
2. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
3. COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. Magro G Virus Res; 2020 Sep; 286():198070. PubMed ID: 32569708 [TBL] [Abstract][Full Text] [Related]
4. Case report study of the first five COVID-19 patients treated with remdesivir in France. Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764 [TBL] [Abstract][Full Text] [Related]
5. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812 [TBL] [Abstract][Full Text] [Related]
6. Rapid review for the anti-coronavirus effect of remdesivir. Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648 [TBL] [Abstract][Full Text] [Related]
7. [Remdesivir for patients with COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516 [No Abstract] [Full Text] [Related]
8. Use of anakinra in severe COVID-19: A case report. Filocamo G; Mangioni D; Tagliabue P; Aliberti S; Costantino G; Minoia F; Bandera A Int J Infect Dis; 2020 Jul; 96():607-609. PubMed ID: 32437934 [TBL] [Abstract][Full Text] [Related]
9. Use of remdesivir for patients with Covid-19: a review article. Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. Gonzales-Zamora JA; Quiroz T; Vega AD Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623 [TBL] [Abstract][Full Text] [Related]
11. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. Helleberg M; Niemann CU; Moestrup KS; Kirk O; Lebech AM; Lane C; Lundgren J J Infect Dis; 2020 Sep; 222(7):1103-1107. PubMed ID: 32702095 [TBL] [Abstract][Full Text] [Related]
12. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
13. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
14. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232 [No Abstract] [Full Text] [Related]
15. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. Chua KP; Conti RM JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187 [No Abstract] [Full Text] [Related]
16. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029 [No Abstract] [Full Text] [Related]
18. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Saha A; Sharma AR; Bhattacharya M; Sharma G; Lee SS; Chakraborty C Arch Med Res; 2020 Aug; 51(6):585-586. PubMed ID: 32439198 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Trials; 2020 May; 21(1):422. PubMed ID: 32448345 [TBL] [Abstract][Full Text] [Related]
20. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]